Filing Details
- Accession Number:
- 0001501134-20-000084
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-24 16:59:54
- Reporting Period:
- 2020-11-20
- Accepted Time:
- 2020-11-24 16:59:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1627766 | E Sean George | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | President & Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-20 | 5,000 | $8.70 | 643,376 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-20 | 1,100 | $46.85 | 642,276 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-20 | 6,677 | $48.08 | 635,599 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-20 | 906 | $48.61 | 634,693 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Options (right to buy) | Disposition | 2020-11-20 | 5,000 | $0.00 | 5,000 | $8.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 45,000 | 2024-10-15 | No | 4 | M | Direct |
Footnotes
- Includes an aggregate of 226,598 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- The sale of common stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2020.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.53 to $47.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.53 to $48.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.53 to $48.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- The option was fully vested on 10/15/2018.
Billionaire Hedge Funds
